IgG-mediated immune suppression to erythrocytes by polyclonal antibodies can occur in the absence of activating or inhibitory Fcγ receptors in a full mouse model

Journal of Immunology

Volumn 195, Issue 5, 2015, Pages 2224-2230

  Bernardo, Lidice ^a,b,c   Yu, Honghui ^a,b,c,d   Amash, Alaa ^a,b   Zimring, James C ^e   Lazarus, Alan H ^a,b,c,f  

^a CANADIAN BLOOD SERVICES   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^e Bloodworks Northwest Research Institute   (United States)

^f UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; HEN EGG LYSOZYME; IMMUNOGLOBULIN F(AB')2 FRAGMENT; IMMUNOGLOBULIN G; LYSOZYME; POLYCLONAL ANTIBODY; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; BLOOD GROUP DUFFY SYSTEM; BLOOD GROUP RHESUS SYSTEM; FC RECEPTOR IIB; IMMUNOGLOBULIN M; MONOCLONAL ANTIBODY; OVALBUMIN; RHESUS D ANTIBODY; RHO(D) ANTIBODY; RHO(D) ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; ERYTHROCYTE; IMMUNE DEFICIENCY; IMMUNOGENICITY; IMMUNOSTIMULATION; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN FUNCTION; WILD TYPE; ANIMAL; BIOLOGICAL MODEL; BLOOD GROUP DUFFY SYSTEM; BLOOD GROUP RHESUS SYSTEM; C57BL MOUSE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; TRANSGENIC MOUSE;

ANIMALS; ANTIBODIES, MONOCLONAL; DUFFY BLOOD-GROUP SYSTEM; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTES; HUMANS; IMMUNE TOLERANCE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MODELS, IMMUNOLOGICAL; MURAMIDASE; OVALBUMIN; RECEPTORS, IGG; RH-HR BLOOD-GROUP SYSTEM; RHO(D) IMMUNE GLOBULIN;

EID: 84940112211     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1500790     Document Type: Article

References (65)

1. Urbaniak, S. J., and M. A. Greiss. 2000. RhD haemolytic disease of the fetus and the newborn. Blood Rev. 14: 44-61.
2. Contreras, M. 1998. The prevention of Rh haemolytic disease of the fetus and newborn-general background. Br. J. Obstet. Gynaecol. 105(Suppl. 18): 7-10.
3. Kumpel, B. M., and C. J. Elson. 2001. Mechanism of anti-D-mediated immune suppression - a paradox awaiting resolution? Trends Immunol. 22: 26-31.
4. Chan, P. L., and N. R. Sinclair. 1973. Regulation of the immune response. VI. Inability of F(ab9) 2 antibody to terminate established immune responses and its ability to interfere with IgG antibody-mediated immunosuppression. Immunology 24: 289-301.
5. Kumpel, B. M. 2007. Efficacy of RhD monoclonal antibodies in clinical trials as replacement therapy for prophylactic anti-D immunoglobulin: more questions than answers. Vox Sang. 93: 99-111.
6. Kumpel, B. M. 2008. Lessons learnt from many years of experience using anti-D in humans for prevention of RhD immunization and haemolytic disease of the fetus and newborn. Clin. Exp. Immunol. 154: 1-5.
7. Heyman, B. 2014. Antibodies as natural adjuvants. Curr. Top. Microbiol. Immunol. 382: 201-219.
8. Frandsen, T. P., H. Naested, S. K. Rasmussen, P. Hauptig, F. C. Wiberg, L. K. Rasmussen, A. M. Jensen, P. Persson, M. Wikén, A. Engström, et al. 2011. Consistent manufacturing and quality control of a highly complex recombinant polyclonal antibody product for human therapeutic use. Biotechnol. Bioeng. 108: 2171-2181.
9. Stasi, R. 2010. Rozrolimupab, symphobodies against rhesus D, for the potential prevention of hemolytic disease of the newborn and the treatment of idiopathic thrombocytopenic purpura. Curr. Opin. Mol. Ther. 12: 734-740.
10. Robak, T., J. Windyga, J. Trelinski, M. von Depka Prondzinski, A. Giagounidis, C. Doyen, A. Janssens, M. T. Alvarez-Román, I. Jarque, J. Loscertales, et al. 2012. Rozrolimupab, a mixture of 25 recombinant human monoclonal RhD antibodies, in the treatment of primary immune thrombocytopenia. Blood 120: 3670-3676.
11. Goossens, D., N. da Silva, S. Metral, U. Cortes, I. Callebaut, J. Picot, I. Mouro- Chanteloup, and J. P. Cartron. 2013. Mice expressing RHAG and RHD human blood group genes. PLoS One 8: e80460.
12. Brinc, D., H. Le-Tien, A. R. Crow, J. W. Semple, J. Freedman, and A. H. Lazarus. 2010. Transfusion of antibody-opsonized red blood cells results in a shift in the immune response from the red blood cell to the antibody in a murine model. Transfusion 50: 2016-2025.
13. Brinc, D., H. Le-Tien, A. R. Crow, V. Siragam, J. Freedman, and A. H. Lazarus. 2008. Transfusion of IgG-opsonized foreign red blood cells mediates reduction of antigen-specific B cell priming in a murine model. J. Immunol. 181: 948-953.
14. Woodrow, J. C., C. A. Clarke, W. T. Donohow, R. Finn, R. B. McConnell, P. M. Sheppard, D. Lehane, F. M. Roberts, and T. M. Gimlette. 1975. Mechanism of Rh prophylaxis: an experimental study on specificity of immunosuppression. BMJ 2: 57-59.
15. Ravetch, J. V., and L. L. Lanier. 2000. Immune inhibitory receptors. Science 290: 84-89.
16. Karlsson, M. C., S. Wernersson, T. Diaz de Ståhl, S. Gustavsson, and B. Heyman. 1999. Efficient IgG-mediated suppression of primary antibody responses in Fcγ receptor-deficient mice. Proc. Natl. Acad. Sci. USA 96: 2244-2249.
17. Brüggemann, M., and K. Rajewsky. 1982. Regulation of the antibody response against hapten-coupled erythrocytes by monoclonal antihapten antibodies of various isotypes. Cell. Immunol. 71: 365-373.
18. Brinc, D., H. Le-Tien, A. R. Crow, V. Siragam, J. Freedman, and A. H. Lazarus. 2008. Immunoglobulin G-mediated regulation of the murine immune response to transfused red blood cells occurs in the absence of active immune suppression: implications for the mechanism of action of anti-D in the prevention of haemolytic disease of the fetus and newborn? Immunology 124: 141-146.
19. Brinc, D., H. Le-Tien, A. R. Crow, J. Freedman, and A. H. Lazarus. 2007. IgGmediated immunosuppression is not dependent on erythrocyte clearance or immunological evasion: implications for the mechanism of action of anti-D in the prevention of haemolytic disease of the newborn? Br. J. Haematol. 139: 275-279.
20. Brinc, D., H. Le-Tien, A. R. Crow, V. Siragam, J. Freedman, and A. H. Lazarus. 2008. Transfusion of IgG-opsonized foreign red blood cells mediates reduction of antigen-specific B cell priming in a murine model. J. Immunol. 181: 948-953.
21. Brinc, D., H. Le-Tien, A. R. Crow, J. W. Semple, J. Freedman, and A. H. Lazarus. 2010. Transfusion of antibody-opsonized red blood cells results in a shift in the immune response from the red blood cell to the antibody in a murine model. Transfusion 50: 2016-2025.
22. Rutemark, C., A. Bergman, A. Getahun, J. Hallgren, F. Henningsson, and B. Heyman. 2012. Complement receptors 1 and 2 in murine antibody responses to IgM-complexed and uncomplexed sheep erythrocytes. PLoS One 7: e41968.
23. Getahun, A., and B. Heyman. 2009. Studies on the mechanism by which antigenspecific IgG suppresses primary antibody responses: evidence for epitope masking and decreased localization of antigen in the spleen. Scand. J. Immunol. 70: 277-287.
24. Karlsson, M. C., A. Getahun, and B. Heyman. 2001. FcγRIIB in IgG-mediated suppression of antibody responses: different impact in vivo and in vitro. J. Immunol. 167: 5558-5564.
25. Karlsson, M. C., T. Diaz de Ståhl, and B. Heyman. 2001. IgE-mediated suppression of primary antibody responses in vivo. Scand. J. Immunol. 53: 381-385.
26. Kumpel, B. M. 2002. On the mechanism of tolerance to the Rh D antigen mediated by passive anti-D (Rh D prophylaxis). Immunol. Lett. 82: 67-73.
27. Girard-Pierce, K. R., S. R. Stowell, N. H. Smith, C. M. Arthur, H. C. Sullivan, J. E. Hendrickson, and J. C. Zimring. 2013. A novel role for C3 in antibodyinduced red blood cell clearance and antigen modulation. Blood 122: 1793-1801.
28. Zimring, J. C., G. A. Hair, T. E. Chadwick, S. S. Deshpande, K. M. Anderson, C. D. Hillyer, and J. D. Roback. 2005. Nonhemolytic antibody-induced loss of erythrocyte surface antigen. Blood 106: 1105-1112.
29. Pearlman, D. S. 1967. The influence of antibodies on immunologic responses. I. The effect on the response to particulate antigen in the rabbit. J. Exp. Med. 126: 127-148.
30. Ding, Z., A. Bergman, C. Rutemark, R. Ouchida, H. Ohno, J. Y. Wang, and B. Heyman. 2013. Complement-activating IgM enhances the humoral but not the T cell immune response in mice. PLoS One 8: e81299.
31. Auffray, I., S. Marfatia, K. de Jong, G. Lee, C. H. Huang, C. Paszty, M. J. Tanner, N. Mohandas, and J. A. Chasis. 2001. Glycophorin A dimerization and band 3 interaction during erythroid membrane biogenesis: in vivo studies in human glycophorin A transgenic mice. Blood 97: 2872-2878.
32. Chaudhuri, A., G. Yuen, F. Fang, and J. Storry. 2004. Development of Duffy transgenic mouse: in vivo expression of human Duffy gene with -33T→C promoter mutation in non-erythroid tissues. Br. J. Haematol. 127: 356-359.
33. Smith, N. H., K. L. Henry, C. M. Cadwell, A. Bennett, J. E. Hendrickson, T. Frame, and J. C. Zimring. 2012. Generation of transgenic mice with antithetical KEL1 and KEL2 human blood group antigens on red blood cells. Transfusion 52: 2620-2630.
34. Desmarets, M., C. M. Cadwell, K. R. Peterson, R. Neades, and J. C. Zimring. 2009. Minor histocompatibility antigens on transfused leukoreduced units of red blood cells induce bone marrow transplant rejection in a mouse model. Blood 114: 2315-2322.
35. Hartley, S. B., J. Crosbie, R. Brink, A. B. Kantor, A. Basten, and C. C. Goodnow. 1991. Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature 353: 765-769.
36. Yu, H., S. R. Stowell, L. Bernardo, J. E. Hendrickson, J. C. Zimring, A. Amash, M. Uchikawa, and A. H. Lazarus. 2014. Antibody-mediated immune suppression of erythrocyte alloimmunization can occur independently from red cell clearance or epitope masking in a murine model. J. Immunol. 193: 2902-2910.
37. Freedman, J., and A. H. Lazarus. 1995. Applications of flow cytometry in transfusion medicine. Transfus. Med. Rev. 9: 87-109.
38. Bruhns, P. 2012. Properties of mouse and human IgG receptors and their contribution to disease models. Blood 119: 5640-5649.
39. Martin, R. M., J. L. Brady, and A. M. Lew. 1998. The need for IgG2c specific antiserum when isotyping antibodies from C57BL/6 and NOD mice. J. Immunol. Methods 212: 187-192.
40. Esser-von Bieren, J., B. Volpe, M. Kulagin, D. B. Sutherland, R. Guiet, A. Seitz, B. J. Marsland, J. S. Verbeek, and N. L. Harris. 2015. Antibody-mediated trapping of helminth larvae requires CD11b and Fcγ receptor I. J. Immunol. 194: 1154-1163.
41. Miyajima, I., D. Dombrowicz, T. R. Martin, J. V. Ravetch, J. P. Kinet, and S. J. Galli. 1997. Systemic anaphylaxis in the mouse can be mediated largely through IgG1 and FcγRIII: assessment of the cardiopulmonary changes, mast cell degranulation, and death associated with active or IgE- or IgG1-dependent passive anaphylaxis. J. Clin. Invest. 99: 901-914.
42. Muta, T., T. Kurosaki, Z. Misulovin, M. Sanchez, M. C. Nussenzweig, and J. V. Ravetch. 1994. A 13-amino-acid motif in the cytoplasmic domain of FcγRIIB modulates B-cell receptor signalling. Nature 368: 70-73.
43. Amigorena, S., C. Bonnerot, J. R. Drake, D. Choquet, W. Hunziker, J. G. Guillet, P. Webster, C. Sautes, I. Mellman, and W. H. Fridman. 1992. Cytoplasmic domain heterogeneity and functions of IgG Fc receptors in B lymphocytes. Science 256: 1808-1812.
44. Bijsterbosch, M. K., and G. G. Klaus. 1985. Crosslinking of surface immunoglobulin and Fc receptors on B lymphocytes inhibits stimulation of inositol phospholipid breakdown via the antigen receptors. J. Exp. Med. 162: 1825-1836.
45. Leontyev, D., Y. Katsman, and D. R. Branch. 2012. Mouse background and IVIG dosage are critical in establishing the role of inhibitory Fcγ receptor for the amelioration of experimental ITP. Blood 119: 5261-5264.
46. Crow, A. R., A. Amash, and A. H. Lazarus. 2015. CD44 antibody-mediated amelioration of murine immune thrombocytopenia (ITP): mouse background determines the effect of FcγRIIb genetic disruption. Transfusion 55: 1492-1500.
47. Bazin, R., R. Lemieux, and T. Tremblay. 2006. Reversal of immune thrombocytopenia in mice by cross-linking human immunoglobulin G with a highaffinity monoclonal antibody. Br. J. Haematol. 135: 97-100.
48. Enriquez-Rincon, F., and G. G. Klaus. 1984. Differing effects of monoclonal anti-hapten antibodies on humoral responses to soluble or particulate antigens. Immunology 52: 129-136.
49. Wiersma, E. J., P. G. Coulie, and B. Heyman. 1989. Dual immunoregulatory effects of monoclonal IgG-antibodies: suppression and enhancement of the antibody response. Scand. J. Immunol. 29: 439-448.
50. Heyman, B., and H. Wigzell. 1984. Immunoregulation by monoclonal sheep erythrocyte-specific IgG antibodies: suppression is correlated to level of antigen binding and not to isotype. J. Immunol. 132: 1136-1143.
51. Greenbury, C. L., and D. H. Moore. 1968. Non-specific antibody-induced suppression of the immune response. Nature 219: 526-527.
52. Sinclair, N. R., R. K. Lees, and E. V. Elliott. 1968. Role of the Fc fragment in the regulation of the primary immune response. Nature 220: 1048-1049.
53. Heyman, B. 1990. Fc-dependent IgG-mediated suppression of the antibody response: fact or artefact? Scand. J. Immunol. 31: 601-607.
54. Hudson, K. E., E. Lin, J. E. Hendrickson, A. E. Lukacher, and J. C. Zimring. 2010. Regulation of primary alloantibody response through antecedent exposure to a microbial T-cell epitope. Blood 115: 3989-3996.
55. Na, D., D. Kim, and D. Lee. 2006. Mathematical modeling of humoral immune response suppression by passively administered antibodies in mice. J. Theor. Biol. 241: 830-851.
56. Dong, X., W. J. Storkus, and R. D. Salter. 1999. Binding and uptake of agalactosyl IgG by mannose receptor on macrophages and dendritic cells. J. Immunol. 163: 5427-5434.
57. Raju, T. S., J. B. Briggs, S. M. Borge, and A. J. Jones. 2000. Species-specific variation in glycosylation of IgG: evidence for the species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics. Glycobiology 10: 477-486.
58. Heyman, B., M. Nose, and W. O. Weigle. 1985. Carbohydrate chains on IgG2b: a requirement for efficient feedback immunosuppression. J. Immunol. 134: 4018-4023.
59. Zimring, J. C., C. M. Cadwell, T. E. Chadwick, S. L. Spitalnik, D. A. Schirmer, T. Wu, C. A. Parkos, and C. D. Hillyer. 2007. Nonhemolytic antigen loss from red blood cells requires cooperative binding of multiple antibodies recognizing different epitopes. Blood 110: 2201-2208.
60. Vengelen-Tyler, V., B. Gonzalez, G. Garratty, C. Kruppe, C. L. Johnson, K. A. Mueller, and W. L. Marsh. 1987. Acquired loss of red cell Kell antigens. Br. J. Haematol. 65: 231-234.
61. Williamson, L. M., J. Poole, C. Redman, N. Clark, Y. W. Liew, D. C. Russo, S. Lee, M. E. Reid, and A. J. Black. 1994. Transient loss of proteins carrying Kell and Lutheran red cell antigens during consecutive relapses of autoimmune thrombocytopenia. Br. J. Haematol. 87: 805-812.
62. Seyfried, H., B. Górska, S. Maj, T. Sylwestrowicz,C.M.Giles, and K. L.Goldsmith. 1972. Apparent depression of antigens of the Kell blood group system associated with autoimmune acquired haemolytic anaemia. Vox Sang. 23: 528-536.
63. Issitt, P. D., R. A. Gruppo, S. L. Wilkinson, and C. H. Issitt. 1982. Atypical presentation of acute phase, antibody-induced haemolytic anaemia in an infant. Br. J. Haematol. 52: 537-543.
64. Ganly, P. S., M. A. Laffan, I. Owen, and J. M. Hows. 1988. Auto-anti-Jka in Evans' syndrome with negative direct antiglobulin test. Br. J. Haematol. 69: 537-539.
65. Issitt, P. D., G. Obarski, P. L. Hartnett, M. R. Wren, and P. L. Prewitt. 1990. Temporary suppression of Kidd system antigen expression accompanied by transient production of anti-Jk3. Transfusion 30: 46-50.